Sustained release of a dual antimalarial system

Authors:

Abstract
The sustained release of a dual drug system in a biodegradable carrier was evaluated in rhesus monkeys and mice. The two drugs were sulphadiazine (WR-7557) (3H-labelled) and 2,4-diamino-6-(2-naphthylsulphonyl)quinazoIine (WR-158122) (14C-Iabelled). The carrier was a polymer of L-lactide (90 parts by weight) and glycolide (10 parts), with a molecular weight of 46 000. The dual system injected was a blend of two preparations, each 50% (w/w) of the appropriate drug in the polymer, in a weight ratio of ten parts of the sulphadiazine system to one part of the WR-158122 system. This blend, as cryogenically ground particles, was injected intramuscularly into three monkeys; a fourth monkey received an equivalent dose of a 10:1 mixture of the pure drugs. Excretion of radioactivity in urine and faeces was measured over 13 weeks. Similar studies were done with mice. In monkeys, 14C-labelled material derived from WR-158122 was excreted at a nearly uniform rate; expressed as WR-158122, the rate of excretion from the pure drug mix was approximately 50 μg day−1 from week three to week 13, while the drug/polymer matrix released the drug at approximately 26 μg day−1 during this period. Recovery of tritiated materials derived from sulphadiazine was approximately 82% of the injected dose in the first three weeks and only a slight difference in release characteristics of the pure drug mix and the mixed drug/polymer matrices was observed. Results of studies with both mice and monkeys were generally consistent.

This publication has 3 references indexed in Scilit: